What Does Nurix Therapeutics Do?

Total employees351
HeadquartersSan Francisco
Founded2012

Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Their proprietary DELigase™ platform enables the discovery of therapies that can either degrade or elevate protein levels, offering potential treatments for a wide range of diseases. Nurix is advancing a pipeline of internally developed and partnered programs, targeting historically challenging drug targets.

Where Is Nurix Therapeutics's Headquarters?

HQ Function

The headquarters serves as the central hub for research and development, corporate strategy, clinical operations, and administrative functions.

Notable Features:

The facility is equipped with state-of-the-art laboratories for drug discovery and development, including capabilities for high-throughput screening and protein engineering, situated within a modern life sciences campus.

Work Culture:

Nurix fosters a science-driven, innovative, and collaborative work environment. Employees are typically passionate about advancing medical science and bringing new therapies to patients with unmet needs. The culture emphasizes teamwork, intellectual curiosity, and a fast-paced approach to research.

HQ Significance:

The San Francisco headquarters places Nurix at the epicenter of biotech innovation, facilitating access to top talent, research institutions, and venture capital, crucial for its growth and development of novel therapeutics.

Values Reflected in HQ: The headquarters reflects Nurix's commitment to cutting-edge science, innovation, and efficient operations aimed at accelerating drug development.

Location:

While headquartered in San Francisco, USA, Nurix Therapeutics conducts global clinical trials for its drug candidates. Its collaborations with international pharmaceutical companies like Sanofi and Gilead also extend its research and potential commercial reach worldwide. The company aims to develop therapies that can address patient needs globally.

Street Address:

1700 Owens Street, Suite 205

City:

San Francisco

State/Province:

CA

Country:

USA

Where Else Does Nurix Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Nurix Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Nurix Therapeutics? Meet the Executive Team

As of April 2025, Nurix Therapeutics' leadership includes:

Arthur T. Sands, M.D., Ph.D. - President & Chief Executive Officer
Pierre S. ThemeData, Ph.D. - Chief Scientific Officer
Christine Ring, M.D., Ph.D. - Chief Medical Officer
Paula Soteropoulos - Chief Business Development and Strategy Officer
Hans V. Pope - Chief Operating Officer
Pasit Phiasivongsa - Chief Technical Officer
Hannah B. Petcov - Chief Financial Officer and Treasurer

Who's Investing in Nurix Therapeutics?

Nurix Therapeutics has been backed by several prominent investors over the years, including:

The Column Group
Third Rock Ventures
Foresite Capital
Sanofi Ventures
Gilead Sciences (as a collaborator with investment)
Various public market institutional investors (since IPO)

What Leadership Changes Has Nurix Therapeutics Seen Recently?

Hire2
Exits0

Nurix Therapeutics has seen strategic additions to its leadership team in the past year, particularly strengthening its clinical and business development functions to support pipeline advancement and corporate growth. No major C-suite departures have been publicly announced recently.

New Appointments:

Christine Ring, M.D., Ph.D., Dr. Christine Ring appointed as Chief Medical Officer.
Paula Soteropoulos, Paula Soteropoulos joined as Chief Business Development and Strategy Officer.

What Technology (Tech Stack) Is Used byNurix Therapeutics?

Discover the tools Nurix Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Nurix Therapeutics Email Formats and Examples

Nurix Therapeutics primarily utilizes the email format [first_initial][last]@nurixtx.com. This is a common format for companies in the biopharmaceutical industry.

[first_initial][last]@nurixtx.com

Format

jsmith@nurixtx.com

Example

85%

Success rate

What's the Latest News About Nurix Therapeutics?

GlobeNewswireMay 28, 2024

Nurix Therapeutics to Present at the Jefferies Healthcare Conference

Nurix Therapeutics announced that its President and CEO, Arthur T. Sands, M.D., Ph.D., will present at the Jefferies Healthcare Conference on June 5, 2024. The presentation will likely cover company progress and pipeline updates....more

GlobeNewswireMay 13, 2024

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

Nurix reported its Q1 2024 financial results, highlighting progress in its clinical programs, including NX-5948 for B-cell malignancies and NX-2127 for various B-cell cancers. The company also discussed upcoming milestones and its financial position....more

GlobeNewswireApril 8, 2024

Nurix Therapeutics Presents Updated Clinical Data from NX-5948 Phase 1a Study in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia at the 2024 AACR Annual Meeting

Nurix presented positive updated data from its Phase 1a trial of NX-5948 in patients with relapsed/refractory CLL, showing promising efficacy and a favorable safety profile. The data supports further development of this BTK degrader....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Nurix Therapeutics, are just a search away.